These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 8232727

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Velnacrine thiaanalogues as potential agents for treating Alzheimer's disease.
    Tabarrini O, Cecchetti V, Temperini A, Filipponi E, Lamperti MG, Fravolini A.
    Bioorg Med Chem; 2001 Nov; 9(11):2921-8. PubMed ID: 11597473
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tacrines as Therapeutic Agents for Alzheimer's Disease. V. Recent Developments.
    Bautista-Aguilera ÓM, Ismaili L, Iriepa I, Diez-Iriepa D, Chabchoub F, Marco-Contelles J, Pérez M.
    Chem Rec; 2021 Jan; 21(1):162-174. PubMed ID: 33169934
    [Abstract] [Full Text] [Related]

  • 7. Velnacrine for Alzheimer's disease.
    Birks J, Wilcock GG.
    Cochrane Database Syst Rev; 2004 Jan; (2):CD004748. PubMed ID: 15106259
    [Abstract] [Full Text] [Related]

  • 8. Design, synthesis, and molecular-modeling study of aminothienopyridine analogues of tacrine for Alzheimer's disease.
    Badran MM, Abdel Hakeem M, Abuel-Maaty SM, El-Malah A, Abdel Salam RM.
    Arch Pharm (Weinheim); 2010 Oct; 343(10):590-601. PubMed ID: 20925094
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and evaluation of tacrine-E2020 hybrids as acetylcholinesterase inhibitors for the treatment of Alzheimer's disease.
    Shao D, Zou C, Luo C, Tang X, Li Y.
    Bioorg Med Chem Lett; 2004 Sep 20; 14(18):4639-42. PubMed ID: 15324879
    [Abstract] [Full Text] [Related]

  • 10. Effects of velnacrine, tacrine and physostigmine on tetanic twitch responses at the rat neuromuscular junction.
    Bosch F, Morales M, Badia A, Baños JE.
    Eur J Pharmacol; 1992 Nov 03; 222(1):163-6. PubMed ID: 1468493
    [Abstract] [Full Text] [Related]

  • 11. Comparative effects of velnacrine, tacrine and physostigmine on the twitch responses in the rat phrenic-hemidiaphragm preparation.
    Bosch F, Morales M, Badia A, Baños JE.
    Gen Pharmacol; 1993 Sep 03; 24(5):1101-5. PubMed ID: 8270168
    [Abstract] [Full Text] [Related]

  • 12. Biphasic effect of tacrine on acetylcholine release in rat brain via M1 and M2 receptors.
    Svensson AL, Zhang X, Nordberg A.
    Brain Res; 1996 Jul 08; 726(1-2):207-12. PubMed ID: 8836562
    [Abstract] [Full Text] [Related]

  • 13. Variability in the plasma protein binding of velnacrine (1-hydroxy tacrine hydrochloride). A potential agent for Alzheimer's disease.
    Wood DM, Ford JM, Roberts CJ.
    Eur J Clin Pharmacol; 1996 Jul 08; 50(1-2):115-9. PubMed ID: 8739821
    [Abstract] [Full Text] [Related]

  • 14. Cytotoxicity of tacrine and velnacrine metabolites in cultured rat, dog and human hepatocytes.
    Viau CJ, Curren RD, Wallace K.
    Drug Chem Toxicol; 1993 Jul 08; 16(3):227-39. PubMed ID: 8404544
    [Abstract] [Full Text] [Related]

  • 15. Novel tacrine analogs as potential cholinesterase inhibitors in Alzheimer's disease.
    El-Malah A, Gedawy EM, Kassab AE, Salam RM.
    Arch Pharm (Weinheim); 2014 Feb 08; 347(2):96-103. PubMed ID: 24343873
    [Abstract] [Full Text] [Related]

  • 16. Design, synthesis and evaluation of tacrine-flurbiprofen-nitrate trihybrids as novel anti-Alzheimer's disease agents.
    Chen Y, Sun J, Huang Z, Liao H, Peng S, Lehmann J, Zhang Y.
    Bioorg Med Chem; 2013 May 01; 21(9):2462-70. PubMed ID: 23541836
    [Abstract] [Full Text] [Related]

  • 17. Effectiveness and safety of velnacrine for the treatment of Alzheimer's disease. A double-blind, placebo-controlled study. Mentane Study Group.
    Antuono PG.
    Arch Intern Med; 1995 Sep 11; 155(16):1766-72. PubMed ID: 7654110
    [Abstract] [Full Text] [Related]

  • 18. Side effects of long acting cholinesterase inhibitors.
    Beermann B.
    Acta Neurol Scand Suppl; 1993 Sep 11; 149():53-4. PubMed ID: 8128840
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.